Overview
McDermott Will & Emery advised Voluntis, a leader in digital therapies, on the signing of a collaboration and licensing agreement with Japanese company Eisai, to design and develop supportive innovative digital therapies (DTx) for cancer patients.
In addition to oncology, the partnership will explore the possibility of a second collaboration in neurology.
The team that advised Voluntis consisted of:
- Emmanuelle Trombe, partner, Anne-France Moreau, partner and Lorraine Maisnier Boche, associate
.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective — and often unexpected — solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
